Otsuka Pharmaceutical has been actively developing pharmaceuticals for the global market ever since the establishment of a research and development division in 1971. The company is constantly focused on resolving medical issues associated with curing disease and improving the quality of life (QOL), aspiring to develop innovative pharmaceuticals to aid in treating disorders of the central nervous system; cancer; cardiovascular, gastrointestinal and respiratory ailments; infectious diseases; and in the areas of ophthalmology and dermatology. New drug development is also progressing in the fields of aquaretics, tuberculosis, epilepsy and rheumatism.
Based on a global strategy for the development and commercialization of pharmaceuticals, preclinical research is conducted in Japan, the US and China, while clinical development occurs mainly in Japan, the US, Europe and Asia, utilizing an extensive network of research facilities both within and outside Japan for global research and development.
Otsuka Pharmaceutical is engaged in the development of nutrition products to maintain and improve day-to-day well-being, based on the concept of "Nutraceuticals".
Otsuka Pharmaceutical conducts scientific research into the nutrition needs of different ages and health conditions, and have created new markets by applying the expertise acquired in its pharmaceutical research to the creation of innovative products such as Pocari Sweat, an electrolytes supply drink prompted by the idea of intravenous hydration, balanced nutritional food CalorieMate, and dietary fiber drink Fibe-Mini. In recent years, Otsuka Pharmaceutical has been focusing on the boundless potential of the nutritional components of soybeans, and has developed SOYJOY, a fruit soy bar offering a "new way of consuming soybeans". In addition, it is promoting its "Soylution*1" concept around the world based on the belief that soybeans could provide a solution to health and diet ary issues.
Research and development of "Cosmedics*2" since 1990 has recently borne fruit in the form of a succession of products in the InnerSignal and UL･OS ranges. Otsuka Pharmaceutical aims to continue to research and develop new Nutraceuticals products for a global market.
- *1 Soylution = soy + solution
- *2 Cosmedics = cosmetic + medicine